# Technology Guarantee Fund

> Technology Guarantee Fund is a VC fund backing Manufacturing, Health Care and Biotechnology. See 27 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 27
- Last investment: Jul 2025
- Lead investor: 26%
- Last updated: Aug 2026

Technology Guarantee Fund is an investment firm.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $884k–$6.8M |
| Series A | $1.4M–$7.3M |
| Series B | $7k–$6.6M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 5 | 19% |
| Health Care | 3 | 11% |
| Biotechnology | 3 | 11% |
| Pharmaceutical | 3 | 11% |
| Artificial Intelligence | 3 | 11% |

62 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 19 | 70% |
| Series A | 4 | 15% |
| Series B | 2 | 7% |
| Pre-Seed | 1 | 4% |
| Venture - Series Unknown | 1 | 4% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 24 | 89% |
| Russian Federation | 1 | 4% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Beyond Honeycomb | Beyond Honeycomb is a food-tech company developing an AI-driven kitchen robot solution. Our AI Chef reproduces the texture and taste of the world-class chef’s dish at the molecular level. | $7.3M | Series A | Jul 09, 2025 |  |
| LYNK Solutec | LYNK Solutec is a laboratory-based company that specializes in bio-medical devices. | $1M | Seed | Mar 19, 2025 |  |
| DK Fine Chemical | DK Fine Chemical is committed to providing essential cellulose-based solutions that play a crucial role in various industries, including construction, paint, coatings, food, pharmaceuticals, personal care, and more. The company focuses on delivering high-quality, sustainable, and innovative cellulose compounds, tailored to meet the diverse needs ofits clients across these sectors. | $4.1M | Seed | Jan 06, 2025 |  |
| D-ZARD | D-ZARD is a next-generation game studio garnering attention for its development capabilities and unique IP. D-ZARD is accelerating the development of the return of a masterpiece, Princess Maker COR (Karen), and the stylish action battle royale Asurajang. | $6.8M | Seed | Dec 30, 2024 |  |
| Seoul Trading Unlisted | Seoul Exchange Unlisted operates a platform for trading unlisted shares. It enables secondary market transactions of private company equity and is designated as an innovative financial service provider by the Financial Services Commission. The platform works in partnerships and provides electronic order matching and execution for share transactionswithout requiring direct consultation. | $1.4M | Series A | Dec 11, 2024 |  |
| Data Company | Data Company is a big data analytics company. | $2.2M | Series A | Jul 19, 2024 |  |
| DewCell | Dewcell Biotherapeutics develops synthetic platelets using biomimetic technology. The company's system secures stem cell differentiation technology into megakaryocytes that generate platelets and mass-produces artificial platelets. | $6.6M | Series B | Apr 29, 2024 |  |
| DeepFine | DeepFine is an AI and sensor fusion solution company that makes life easier with innovative technology. Its first project is an AI personal shopper called Fairy Cart which provides a variety of information and benefits for smart shopping. It is equipped with AI technology to analyze customer's consumption pattern and provide personalizationservice. | $5.1M | Series A | Dec 28, 2023 |  |
| Pixel House | Loka101 appears to be a South Korean residential living and co-living platform operating shared housing and premium goshiwon-style accommodations under the “Pixel House” and “Loka House” brands. The company provides affordable urban housing solutions for students, young professionals, and single residents through managed residential properties anddigital booking services. | $1.2M | Seed | Dec 22, 2023 |  |
| BeauBrain Healthcare | Alzheimer’s Disease is one of the most prevalent neurodegenerative diseases causing insufferable pain to patients and their families. There are over 55 million people worldwide living with dementia, and Alzheimer’s Disease is the most common form of dementia. Unfortunately, the aging population will only exacerbate the prevalence of the disease,yielding immense medical costs in addition to the already devastating social burden. At BeauBrain Healthcare, we are revolutionizing the current treatment paradigm from “post-diagnosis treatment” to “pre-emptive intervention.”Our solutions enable early identification of the disease through predictive analysis of disease-specific biomarkers (Amyloid Beta, Tau, Neurodegeneration), and a personalized cognitive training platform (DTx). Ultimately, our long-term vision is to realize precision medicine for Alzheimer’s disease through the biomarker data generated from our diverse solutions combined with a vast amount of genetic data. | $2.3M | Seed | Dec 22, 2023 |  |

10 of 27 investments shown.

## Co-investors
- [Korea Technology Finance Corporation](https://shizune.co/investors/profile/korea-technology-finance-corporation) — VC Fund, 8 deals together
- [BNK Venture Capital](https://shizune.co/investors/profile/bnk-venture-capital-c3fd) — VC Fund, 2 deals together
- [Korea Development Bank](https://shizune.co/investors/profile/korean-development-bank) — VC Fund, 2 deals together
- [POSTECH Holdings](https://shizune.co/investors/profile/postech-holdings) — VC Fund, 2 deals together
- [Shinhan Capital](https://shizune.co/investors/profile/shinhan-capital) — VC Fund, 2 deals together
- [Timewise Investment](https://shizune.co/investors/profile/timewise-investment) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Manufacturing Investors in South Korea](https://shizune.co/investors/manufacturing-investors-south-korea)
- [Manufacturing VC Funds in South Korea](https://shizune.co/investors/manufacturing-vc-funds-south-korea)
- [Travel Investors in South Korea](https://shizune.co/investors/travel-investors-south-korea)
- [Travel VC Funds in South Korea](https://shizune.co/investors/travel-vc-funds-south-korea)
- [Climate Investors in South Korea](https://shizune.co/investors/climate-investors-south-korea)
- [Construction Investors in South Korea](https://shizune.co/investors/construction-investors-south-korea)

## FAQ

### What does Technology Guarantee Fund invest in?

Technology Guarantee Fund invests primarily in Manufacturing, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 27 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Technology Guarantee Fund's check size?

Technology Guarantee Fund typically joins rounds of $884k–$6.8M at Seed, $1.4M–$7.3M at Series A and $7k–$6.6M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Technology Guarantee Fund participates in.

### When did Technology Guarantee Fund last invest?

The most recent investment recorded for Technology Guarantee Fund closed in Jul 2025. Shizune tracks 27 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co